|Articles|October 1, 1999

October 1999
Volume 5
Issue 10

Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

Author(s)Sean Z. Zhao, MD, PhD, Lester M. Arguelles, MS, Seema D. Dedhiya, MS

Download PDF: Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

Articles in this issue

almost 27 years ago

Article

A Call to Arms for Managed Care

almost 27 years ago

Article

Experiences of Ethnic Minority Primary Care Physicians with Managed Care: A National Survey

almost 27 years ago

Article

Enhanced Emergency Department Referral Improves Primary Care Access

almost 27 years ago

Article

The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain

almost 27 years ago

Article

Diabetes Managed Care and Clinical Outcomes: The Harbor City, California Kaiser Permanente Diabetes Care System

almost 27 years ago

Article

Understanding, Creating, and Working with Formulary Systems

almost 27 years ago

Article

Equal Employment Opportunity in Managed Care Organizations

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care

Cardiology Prices Vary Widely by Insurer and State

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

Rethinking Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA